Pharmaceutical giant Bristol Myers Squibb is eyeing Houston for a $1B manufacturing plant that would create close to 500 jobs, according to a state filing. 

The 104-acre site in Generation Park, a master-planned business park just outside Beltway 8 in northeast Houston, is one of three sites in three states that the New Jersey-based company is considering, according to an application for tax incentives filed this week with the Texas Comptroller of Public Accounts.

If built in Houston, the facility would bolster the region’s status as a biotech hub, following pharma giant Eli Lilly’s announcement of a $6.5B plant under construction in Generation Park. 

A spokesperson for Bristol Myers Squibb said in a statement to the Houston Chronicle that the company could not confirm which sites it is considering for the plant or its timeline for picking a site. 

“We are conducting an extensive, competitive evaluation of multiple markets in the Central and Eastern U.S. with (Good Manufacturing Practice) manufacturing capabilities and other criteria as potential locations for our domestic manufacturing investment,” the BMS spokesperson said. 

A spokesperson for McCord Development, the developer behind Generation Park, declined to answer questions about the project application, citing confidentiality agreements. The business park has positioned itself as an attractive venue for life sciences companies, and it recently launched a biotech workforce development program in partnership with San Jacinto College.

BMS’ plant would measure at least 600,000 square feet and create 489 jobs, the application states. The company in its application projects that construction would begin in 2027 and wrap in 2029, and that the plant would come online in 2030.

The plant would have a modular, expandable design to allow BMS to add manufacturing capacity quickly. BMS would use the plant to manufacture medicines for “multiple therapeutic areas and modalities,” according to the application. 

The company “sees an opportunity not just to operate in Texas, but to grow with it, contributing to the development of the state’s pharmaceutical manufacturing workforce and establishing a long-term presence in one of the country’s most ambitious emerging life sciences markets,” the application reads. 

Bristol Myers Squibb is a global pharmaceutical company with more than 34,000 employees, according to its website.